Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels |
---|---|---|---|
1 | |||
Agranulocytosis | x | ||
Ataxia | x | ||
Confusional state | x | ||
Constipation | x | ||
Libido decreased | x | ||
Drowsiness | x | ||
Oedema | x | ||
Blood disorder | x | ||
Jaundice | x | ||
Nausea | x | ||
Syncope | x | ||
Hepatic function abnormal | x | ||
Menstruation irregular | x | ||
Extrapyramidal symptoms | x | ||
Eruption | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |